Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699473 | Clinical Oncology | 2008 | 7 Pages |
Abstract
Dose escalation is feasible in pancreatic cancer, particularly when combined with a reduction in irradiated volume, and enhanced efficacy is indicated. Large, globally applied margins to compensate for pancreatic tumour motion during radiotherapy may be inappropriate. Strategies to reduce respiratory motion, and/or the application of image-guided techniques that incorporate individual patients' respiratory motion into radiotherapy planning and delivery, will probably improve pancreatic radiotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.M. Henry, W.D.J. Ryder, C. Moore, D.J. Sherlock, J.I. Geh, P. Dunn, P. Price,